People · Operator
Named in public records as an officer, director or promoter · active 2020–2020 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Palleon Pharmaceuticals Inc. | — | Biotechnology | Series D+ | $120.6M | $3.9B | 2020 |
Eric W. Xiao at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric W. Xiao on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James W. Broderick | 1 | 5 |
| Stephen W. Hoffman | 1 | 2 |
| Karan W. Takhar | 1 | 1 |
| William W. Burkoth | 1 | 1 |
| Rajeev W. Dadoo | 1 | 1 |
| John W. Hennessy | 1 | 1 |
| Karen W. Hong | 1 | 1 |
| James W. Lee | 1 | 1 |
| Jens W. Eckstein | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.